BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34455970)

  • 21. Butyrylcholinesterase in the life cycle of amyloid plaques.
    Guillozet AL; Smiley JF; Mash DC; Mesulam MM
    Ann Neurol; 1997 Dec; 42(6):909-18. PubMed ID: 9403484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice.
    Gnoth K; Geissler S; Feldhaus J; Taudte N; Ilse V; Zürner S; Greiser S; Braumann UD; Rahfeld JU; Cynis H; Schilling S
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin.
    Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease.
    Song Z; Zheng M; Ding J; Xu Y; Ji MJ; Liu C
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33938883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease.
    Govindarajan K; Kar S
    J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.
    Chourrout M; Sandt C; Weitkamp T; Dučić T; Meyronet D; Baron T; Klohs J; Rama N; Boutin H; Singh S; Olivier C; Wiart M; Brun E; Bohic S; Chauveau F
    Acta Biomater; 2023 Oct; 170():260-272. PubMed ID: 37574159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.
    López-Gambero AJ; Rosell-Valle C; Medina-Vera D; Navarro JA; Vargas A; Rivera P; Sanjuan C; Rodríguez de Fonseca F; Suárez J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease.
    Odfalk KF; Wickline JL; Smith S; Dobrowolski R; Hopp SC
    Hippocampus; 2024 Jan; 34(1):29-35. PubMed ID: 37961834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
    J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease.
    Lackie RE; Marques-Lopes J; Ostapchenko VG; Good S; Choy WY; van Oosten-Hawle P; Pasternak SH; Prado VF; Prado MAM
    Acta Neuropathol Commun; 2020 Aug; 8(1):143. PubMed ID: 32825842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging.
    Liu SY; Xiong H; Yang JQ; Yang SH; Li Y; Yang WC; Yang GF
    ACS Sens; 2018 Oct; 3(10):2118-2128. PubMed ID: 30203965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.